Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
VMF
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cortisdin
2. Efflumidex
3. Flucon
4. Flucon, Isopto
5. Fluor Op
6. Fluor-op
7. Fluoro Ophtal
8. Fluoro-ophtal
9. Fluoropos
10. Fml
11. Fml Forte
12. Fml Liquifilm
13. Isopto Flucon
14. Pms Fluorometholone
15. Pms-fluorometholone
1. 426-13-1
2. Fluoromethalone
3. Oxylone
4. Flumetholon
5. Fluor-op
6. Fluormetholone
7. Cortilet
8. Delmeson
9. Fml Liquifilm
10. Trilcin
11. Fml Forte
12. Fluorometolona
13. Fluorometholonum
14. Fluormetholon
15. Nsc 33001
16. Fml
17. Component Of Neo-oxylone
18. U 8614
19. Chebi:31625
20. 9-fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
21. Nsc-33001
22. (6s,8s,9r,10s,11s,13s,14s,17r)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
23. Sv0csg527l
24. Mls000069537
25. Mls001076157
26. Fluormetholonum
27. 9-fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione
28. Nsc33001
29. Fluorometolone
30. Smr000058598
31. Fluorometolone [dcit]
32. Neo-oxylone
33. Fml-s Liquifilm
34. Dsstox_cid_27435
35. Dsstox_rid_82345
36. Fml S.o.p.
37. Dsstox_gsid_47435
38. Fluorometholonum [inn-latin]
39. Fluorometolona [inn-spanish]
40. Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-6-methyl-, (6.alpha.,11.beta.)-
41. Oxylone (tn)
42. Fluor-op (tn)
43. Fml (tn)
44. Einecs 207-041-5
45. Unii-sv0csg527l
46. Fluorometholon
47. Ai3-52813
48. Ncgc00016442-01
49. Cas-426-13-1
50. Prestwick_227
51. 9-fluoro-11-beta,17-dihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
52. Fluorometholone [usp:inn:ban:jan]
53. Mfcd00056461
54. Opera_id_341
55. Prestwick0_000718
56. Prestwick1_000718
57. Prestwick2_000718
58. Prestwick3_000718
59. F0414
60. 11beta,17alpha-dihydroxy-9-fluoro-6-methyl-1,4-pregnadiene-3,20-dione
61. Fluorometholone, >=98%
62. Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17-dihydroxy-6-alpha-methyl-
63. Schembl5051
64. Fluorometholone [mi]
65. Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-6-methyl-, (6alpha,11beta)-
66. Bspbio_000935
67. Fluorometholone [inn]
68. Fluorometholone [jan]
69. Spbio_002856
70. Fluorometholone [vandf]
71. Bpbio1_001029
72. Gtpl7079
73. Fluorometholone [mart.]
74. Chembl1200600
75. Dtxsid7047435
76. Fluorometholone [usp-rs]
77. Fluorometholone [who-dd]
78. 9-fluoro-11.beta.,17-dihydroxy-6.alpha.-methylpregna-1,4-diene-3,20-dione
79. Pregna-1,4-diene-3,20-dione, 9-fluoro-11.beta.,17-dihydroxy-6.alpha.-methyl-
80. Fluorometholone (jp17/usp/inn)
81. Hms1570o17
82. Hms2097o17
83. Hms2234f16
84. Hms3714o17
85. Hy-b1893
86. Tox21_110440
87. Tox21_302593
88. Bdbm50103631
89. Fluorometholone [orange Book]
90. S5486
91. Akos015895108
92. Fml-s Component Fluorometholone
93. Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17-dihydroxy-6alpha-methyl-
94. Tox21_110440_1
95. Zinc118912517
96. Ac-3520
97. Ccg-220718
98. Db00324
99. Fluorometholone [usp Monograph]
100. (6alpha,11beta)-9-fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione
101. Ncgc00021575-03
102. Ncgc00021575-05
103. Ncgc00256631-01
104. As-12363
105. Fluorometholone Component Of Fml-s
106. Nci60_002886
107. Cs-0013955
108. Progesterone, 17-dihydroxy-6.alpha.-methyl-
109. D01367
110. 426f131
111. Q607349
112. Sr-01000003019
113. Sr-01000003019-2
114. Brd-k64862097-001-03-9
115. Brd-k64862097-001-12-0
116. Fluorometholone, British Pharmacopoeia (bp) Reference Standard
117. Fluorometholone, United States Pharmacopeia (usp) Reference Standard
118. Pregna-1,20-dione, 9-fluoro-11.beta.,17-dihydroxy-6.alpha.-methyl-
119. Progesterone, 1-dehydro-9-fluoro-11.beta., 17-dihydroxy-6.alpha.-methyl-
120. Pregna-1,20-dione, 9-fluoro-11,17-dihydroxy-6-methyl-, (6.alpha.,11.beta.)-
121. Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-6-methyl-, (6i+/-,11i(2))-
122. (1r,2s,8s,10s,11s,14r,15s,17s)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one
123. (1r,2s,8s,10s,11s,14r,15s,17s)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one
124. Pregna-1, 4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-6-methyl-, (6.alpha., 11.beta.)-
Molecular Weight | 376.5 g/mol |
---|---|
Molecular Formula | C22H29FO4 |
XLogP3 | 2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 1 |
Exact Mass | 376.20498756 g/mol |
Monoisotopic Mass | 376.20498756 g/mol |
Topological Polar Surface Area | 74.6 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 787 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 4 | |
---|---|
Drug Name | Fml |
PubMed Health | Fluorometholone (Into the eye) |
Drug Classes | Ophthalmologic Agent |
Drug Label | FML (fluorometholone ophthalmic ointment) 0.1% is a sterile, topical anti-inflammatory agent for ophthalmic use.... |
Active Ingredient | Fluorometholone |
Dosage Form | Ointment; Suspension/drops |
Route | Ophthalmic |
Strength | 0.1% |
Market Status | Prescription |
Company | Allergan |
2 of 4 | |
---|---|
Drug Name | Fml forte |
PubMed Health | Fluorometholone (Into the eye) |
Drug Classes | Ophthalmologic Agent |
Drug Label | FML FORTE (fluorometholone ophthalmic suspension, USP) 0.25% is a sterile, topical anti-inflammatory agent for ophthalmic use. Chemical NameFluorometholone: 9-Fluoro-11, 17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione. Structural FormulaContai... |
Active Ingredient | Fluorometholone |
Dosage Form | Suspension/drops |
Route | Ophthalmic |
Strength | 0.25% |
Market Status | Prescription |
Company | Allergan |
3 of 4 | |
---|---|
Drug Name | Fml |
PubMed Health | Fluorometholone (Into the eye) |
Drug Classes | Ophthalmologic Agent |
Drug Label | FML (fluorometholone ophthalmic ointment) 0.1% is a sterile, topical anti-inflammatory agent for ophthalmic use.... |
Active Ingredient | Fluorometholone |
Dosage Form | Ointment; Suspension/drops |
Route | Ophthalmic |
Strength | 0.1% |
Market Status | Prescription |
Company | Allergan |
4 of 4 | |
---|---|
Drug Name | Fml forte |
PubMed Health | Fluorometholone (Into the eye) |
Drug Classes | Ophthalmologic Agent |
Drug Label | FML FORTE (fluorometholone ophthalmic suspension, USP) 0.25% is a sterile, topical anti-inflammatory agent for ophthalmic use. Chemical NameFluorometholone: 9-Fluoro-11, 17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione. Structural FormulaContai... |
Active Ingredient | Fluorometholone |
Dosage Form | Suspension/drops |
Route | Ophthalmic |
Strength | 0.25% |
Market Status | Prescription |
Company | Allergan |
For the ophthalmic treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.
FDA Label
Corticosteroids such as fluorometholone inhibit the inflammatory response to a variety of inciting agents and probably delay or slow healing. They inhibit the edema, fibrin deposition, capillary dilation, leukocyte migration, capillary proliferation, fibroblast proliferation, deposition of collagen, and scar formation associated with inflammation.
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
Glucocorticoids
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
S01BA07
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
C - Cardiovascular system
C05 - Vasoprotectives
C05A - Agents for treatment of hemorrhoids and anal fissures for topical use
C05AA - Corticosteroids
C05AA06 - Fluorometholone
D - Dermatologicals
D07 - Corticosteroids, dermatological preparations
D07A - Corticosteroids, plain
D07AB - Corticosteroids, moderately potent (group ii)
D07AB06 - Fluorometholone
D - Dermatologicals
D07 - Corticosteroids, dermatological preparations
D07X - Corticosteroids, other combinations
D07XB - Corticosteroids, moderately potent, other combinations
D07XB04 - Fluorometholone
D - Dermatologicals
D10 - Anti-acne preparations
D10A - Anti-acne preparations for topical use
D10AA - Corticosteroids, combinations for treatment of acne
D10AA01 - Fluorometholone
S - Sensory organs
S01 - Ophthalmologicals
S01B - Antiinflammatory agents
S01BA - Corticosteroids, plain
S01BA07 - Fluorometholone
S - Sensory organs
S01 - Ophthalmologicals
S01C - Antiinflammatory agents and antiinfectives in combination
S01CB - Corticosteroids/antiinfectives/mydriatics in combination
S01CB05 - Fluorometholone
There is no generally accepted explanation for the mechanism of action of ocular corticosteroids. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. Their primary target is the cytosolic glucocorticoid receptor. After binding the receptor the newly formed receptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes.
NDC Package Code : 22552-0050
Start Marketing Date : 2019-03-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
Human Pharmalabs manufacturer of high quality corticosteroid APIs with a state of the art facility in Kalol Gandhinagar.
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-07-18
Pay. Date : 2024-06-12
DMF Number : 35780
Submission : 2021-04-13
Status : Active
Type : II
NDC Package Code : 46439-8770
Start Marketing Date : 2021-04-21
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2021-02-18
Registration Number : 20210218-211-J-842
Manufacturer Name : Farmabios SpA@IMS srl
Manufacturer Address : Via Pavia 1, 27027 Gropello Cairoli (PV), Italy@Via Venezia Giulia 23, 20157 Milano
Available Reg Filing : EU |
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-04-18
Pay. Date : 2014-04-11
DMF Number : 4423
Submission : 1982-02-03
Status : Active
Type : II
Registration Number : 218MF10387
Registrant's Address : 15 rue Traversie(')re 75012 Paris France
Initial Date of Registration : 2006-03-20
Latest Date of Registration :
NDC Package Code : 82298-119
Start Marketing Date : 2011-02-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2021-05-06
Registration Number : 20210506-211-J-808
Manufacturer Name : EUROAPI France
Manufacturer Address : 4 La Paterie, VERTOLAYE, 63480, France
Available Reg Filing : ASMF |
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
NDC Package Code : 82298-120
Start Marketing Date : 2011-02-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-03-03
Pay. Date : 2022-02-16
DMF Number : 36772
Submission : 2022-02-08
Status : Active
Type : II
Registration Number : 306MF10063
Registrant's Address : Parque Tecnologico-Parcela 105 Boecillo (Valladolid) Spain
Initial Date of Registration : 2024-05-08
Latest Date of Registration :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37674
Submission : 2023-01-03
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1541
Submission : 1970-06-25
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2024-07-18
Pay. Date : 2024-06-12
DMF Number : 35780
Submission : 2021-04-13
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-04-18
Pay. Date : 2014-04-11
DMF Number : 4423
Submission : 1982-02-03
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3108
Submission : 1978-01-16
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-03-03
Pay. Date : 2022-02-16
DMF Number : 36772
Submission : 2022-02-08
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37674
Submission : 2023-01-03
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1541
Submission : 1970-06-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4761
Submission : 1982-12-17
Status : Inactive
Type : II
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
FML suspension (fluorometholone) is a glucocorticoid receptor agonist, with its generic approved by USFDA for corticosteroid-responsive inflammation of the conjunctiva, cornea, and anterior segment.
Lead Product(s): Fluorometholone
Therapeutic Area: Ophthalmology Brand Name: Fluorometholone-Generic
Study Phase: Approved FDFProduct Type: Steroid
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable October 01, 2024
Lead Product(s) : Fluorometholone
Therapeutic Area : Ophthalmology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Amneal Launches Complex Generic Fluorometholone Ophthalmic Suspension
Details : FML suspension (fluorometholone) is a glucocorticoid receptor agonist, with its generic approved by USFDA for corticosteroid-responsive inflammation of the conjunctiva, cornea, and anterior segment.
Product Name : Fluorometholone-Generic
Product Type : Steroid
Upfront Cash : Inapplicable
October 01, 2024
21-Desacetoxy Anecortave Oxediene
CAS Number : 34184-82-2
End Use API : Fluorometholone
About The Company : EUROAPI is focused on reinventing active ingredient solutions to meet the needs of customers and patients worldwide sustainably. We are a leading player in APIs...
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Dosage Form : Cream / Lotion / Ointment, Ophthalmic Solution
Grade : Topical, Parenteral
Category : Solubilizers, Topical
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Application : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.
Brand Name : Benzalkonium Chloride 17% USP NF
Application : Solubilizers
Excipient Details : A&C’s Benzalkonium Chloride 17% is a preservative which meets the NF monograph.
Pharmacopoeia Ref : USP NF
Technical Specs : 17% USP NF
Ingredient(s) : Benzalkonium chloride excipient
Brand Name : Benzalkonium Chloride 50% NF
Application : Solubilizers
Excipient Details : A&C’s Benzalkonium Chloride 50% is a preservative which meets the NF monograph. It acts as a quarternary ammonium salt.
Dosage Form : Capsule, Cream / Lotion / Ointment, Suspension, Tablet
Grade : Oral, Topical & Parenteral
Category : Solubilizers, Surfactant & Foaming Agents
Application : Solubilizers, Surfactant & Foaming Agents
Excipient Details : Polysorbate 80 acts as solubilizer, emulsifier and wetting agent.
Dosage Form : Gel, Softgel Capsule, Solution, Suppository
Grade : Not Available
Category : Solubilizers
Application : Solubilizers
Excipient Details : Nonionic solubilizer, emulsifier and co-emulsifier
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Paste, Shampoo, Solution, Syrup, Tablet
Grade : Topical, Oral
Category : Film Formers & Plasticizers, Solubilizers, Surfactant & Foaming Agents, Topical
Brand Name : MONTANOX 80 PHA PREMIUM
Application : Film Formers & Plasticizers, Solubilizers, Surfactant & Foaming Agents, Topical
Excipient Details : Non-Ionic Hydrophilic Surfactant, Emulsifier, Solubilizer
Pharmacopoeia Ref : Ph.Eur, USP-NF
Technical Specs : HLB: 15, EO: 20; EXCiPACT
Ingredient(s) : Polysorbate 80
Brand Name : Polysorbate 80 Multi-Compendial
Application : Solubilizers
Excipient Details : A & C's Polysorbate 80 multi-compendial is an excipient which meets USP-NF, EP, BP and JP monographs.
Brand Name : Polysorbate 80 NF
Application : Solubilizers
Excipient Details : A & C's Polysorbate 80 is an excipient which meets the NF monograph.
Dosage Form : Capsule, Cream / Lotion / Ointment, Tablet
Grade : Oral, Topical
Category : Emulsifying Agents, Solubilizers, Surfactant & Foaming Agents, Topical
Brand Name : MONTANOX 80 PHA PREMIUM
Application : Emulsifying Agents, Solubilizers, Surfactant & Foaming Agents, Topical
Pharmacopoeia Ref : USP-NF, EP, JP
Technical Specs : Non-Ionic Hydrophilic surfactant, Emulsifier (o/w emulsion), Solu...
Ingredient(s) : Polysorbate 80
Application : Coating Systems & Additives
Excipient Details : Novomix is used as a ready mix film coating system in the production of pharmaceutical tablets.
Dosage Form : Tablet
Grade : Not Available
Category : Coating Systems & Additives, Controlled & Modified Release
Application : Coating Systems & Additives, Controlled & Modified Release
Excipient Details : Immediate Release
Dosage Form : Tablet
Grade : Not Available
Category : Coating Systems & Additives, Controlled & Modified Release
Application : Coating Systems & Additives, Controlled & Modified Release
Excipient Details : Immediate Release
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Dosage Form : Tablet
Grade : Not Available
Category : Coating Systems & Additives, Controlled & Modified Release
Application : Coating Systems & Additives, Controlled & Modified Release
Excipient Details : Immediate Release
Application : Coating Systems & Additives
Excipient Details : Colorcoat FC4S is used as a film coating agednt in various OSDs.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Application : Coating Systems & Additives
Excipient Details : Colorcoat FC4W is used as a film coating agednt in various OSDs.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Application : Coating Systems & Additives
Excipient Details : Colorcoat FC4WS is used as a film coating agednt in various OSDs.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Application : Coating Systems & Additives
Excipient Details : Colorcoat MB4S is used as a film coating agednt in various OSDs.
Application : Coating Systems & Additives
Excipient Details : Moisture Barrier Coating
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Application : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.
Dosage Form : Nasal Solution, Ophthalmic Solution
Grade : Ophthalmic and Nasal
Category : Parenteral
Brand Name : Benzalkonium Chloride
Application : Parenteral
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Benzalkonium chloride excipient
Dosage Form : Capsule, Cream / Lotion / Ointment, Suspension, Tablet
Grade : Oral, Topical & Parenteral
Category : Solubilizers, Surfactant & Foaming Agents
Application : Solubilizers, Surfactant & Foaming Agents
Excipient Details : Polysorbate 80 acts as solubilizer, emulsifier and wetting agent.
Brand Name : Sodium Chloride USP
Application : Parenteral
Excipient Details : A & C's Sodium Chloride is an excipient meeting the USP monograph.
Dosage Form : Injectable / Parenteral, Nasal Solution, Ophthalmic Solution
Grade : Injectable
Category : Parenteral, Solubilizers
Application : Parenteral, Solubilizers
Excipient Details : Non-Ionic Hydrophilic Surfactant, Emulsifier, Solubilizer
Dosage Form : Injectable / Parenteral, Nasal Solution, Ophthalmic Solution
Grade : Injectable
Category : Parenteral, Solubilizers
Application : Parenteral, Solubilizers
Excipient Details : Non-Ionic Hydrophilic Surfactant, Emulsifier, Solubilizer
Brand Name : NaCl Multi-compendial Low Endotoxin
Application : Parenteral
Excipient Details : A & C's Sodium Chloride multi-compendial low endotoxin is an excipient meeting USP-NF, EP, BP and JP monographs.
Pharmacopoeia Ref : Multi-compendial
Technical Specs : Low Endotoxin
Ingredient(s) : Sodium Chloride Excipient
Dosage Form : Injectable / Parenteral, Nasal Solution, Ophthalmic Solution
Grade : Injectable
Category : Parenteral, Solubilizers
Application : Parenteral, Solubilizers
Excipient Details : Non-Ionic Hydrophilic Surfactant, Emulsifier, Solubilizer
Dosage Form : Injectable / Parenteral, Nasal Solution, Ophthalmic Solution
Grade : Injectable
Category : Parenteral, Solubilizers
Brand Name : MONTANOX 80 VG DF RPR D
Application : Parenteral, Solubilizers
Excipient Details : Non-Ionic Hydrophilic Surfactant, Emulsifier, Solubilizer
Dosage Form : Capsule, Gel, Injectable / Parenteral, Ophthalmic Solution, Orodispersible Tablet, Tablet
Grade : Oral, Ophthalmic, Microspher...
Category : Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Parenteral, Topical
Application : Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Parenteral, Topical
Excipient Details : Gohsenol EG acts as a pharmaceutical binder, filler and film former in various dosage forms like opthalmic, microsphere, OD strip and gel patches.
Pharmacopoeia Ref : JPE, USP, EP, ChP (China)
Technical Specs : Highly purified PVA, Partially hydrolysis, having all viscocity g...
Ingredient(s) : Polyvinyl Alcohol
Dosage Form : Cream / Lotion / Ointment, Ophthalmic Solution
Grade : Topical, Parenteral
Category : Solubilizers, Topical
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Application : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.
Dosage Form : Capsule, Cream / Lotion / Ointment, Suspension, Tablet
Grade : Oral, Topical & Parenteral
Category : Solubilizers, Surfactant & Foaming Agents
Application : Solubilizers, Surfactant & Foaming Agents
Excipient Details : Polysorbate 80 acts as solubilizer, emulsifier and wetting agent.
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Paste, Shampoo, Solution, Syrup, Tablet
Grade : Topical, Oral
Category : Film Formers & Plasticizers, Solubilizers, Surfactant & Foaming Agents, Topical
Brand Name : MONTANOX 80 PHA PREMIUM
Application : Film Formers & Plasticizers, Solubilizers, Surfactant & Foaming Agents, Topical
Excipient Details : Non-Ionic Hydrophilic Surfactant, Emulsifier, Solubilizer
Pharmacopoeia Ref : Ph.Eur, USP-NF
Technical Specs : HLB: 15, EO: 20; EXCiPACT
Ingredient(s) : Polysorbate 80
Dosage Form : Capsule, Cream / Lotion / Ointment, Tablet
Grade : Oral, Topical
Category : Emulsifying Agents, Solubilizers, Surfactant & Foaming Agents, Topical
Brand Name : MONTANOX 80 PHA PREMIUM
Application : Emulsifying Agents, Solubilizers, Surfactant & Foaming Agents, Topical
Pharmacopoeia Ref : USP-NF, EP, JP
Technical Specs : Non-Ionic Hydrophilic surfactant, Emulsifier (o/w emulsion), Solu...
Ingredient(s) : Polysorbate 80
Dosage Form : Cream / Lotion / Ointment, Emulsion, Gel
Grade : Topical
Category : Rheology Modifiers, Thickeners and Stabilizers, Topical
Application : Rheology Modifiers, Thickeners and Stabilizers, Topical
Excipient Details : Thickener, Stabilizer / Emulsifier, Texturizing Agent
Pharmacopoeia Ref : IID
Technical Specs : EXCiPACT
Ingredient(s) : Acrylamide / Sodium Acryloyldimethyl Taurate Copolymer Isohexadecane and Polysorbate 80
Dosage Form : Cream / Lotion / Ointment, Emulsion
Grade : Topical
Category : Emulsifying Agents, Rheology Modifiers, Thickeners and Stabilizers, Topical
Application : Emulsifying Agents, Rheology Modifiers, Thickeners and Stabilizers, Topical
Excipient Details : Thickener, Emulsifier, Stabilizer, Texturizing agent, pH Independent & Non Thixotropic polymer for Topical Range (Skin,Vaginal & Anal mucosa)
Pharmacopoeia Ref : In house having US DMF Type IV...
Technical Specs : Ready to use liquid polymer for topical applications (Gel / Cream...
Ingredient(s) : Hydroxyethyl Acrylate
Dosage Form : Capsule, Gel, Injectable / Parenteral, Ophthalmic Solution, Orodispersible Tablet, Tablet
Grade : Oral, Ophthalmic, Microspher...
Category : Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Parenteral, Topical
Application : Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Parenteral, Topical
Excipient Details : Gohsenol EG acts as a pharmaceutical binder, filler and film former in various dosage forms like opthalmic, microsphere, OD strip and gel patches.
Pharmacopoeia Ref : JPE, USP, EP, ChP (China)
Technical Specs : Highly purified PVA, Partially hydrolysis, having all viscocity g...
Ingredient(s) : Polyvinyl Alcohol
Dosage Form : Capsule, Gel, Injectable / Parenteral, Ophthalmic Solution, Orodispersible Tablet, Tablet
Grade : Oral, Ophthalmic, Microspher...
Category : Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Parenteral, Topical
Application : Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Parenteral, Topical
Excipient Details : Gohsenol EG acts as a pharmaceutical binder, filler and film former in various dosage forms like opthalmic, microsphere, OD strip and gel patches.
Pharmacopoeia Ref : JPE, USP, EP, ChP (China)
Technical Specs : Highly purified PVA, Partially hydrolysis, having all viscocity g...
Ingredient(s) : Polyvinyl Alcohol
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
42
PharmaCompass offers a list of Fluorometholone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fluorometholone manufacturer or Fluorometholone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fluorometholone manufacturer or Fluorometholone supplier.
PharmaCompass also assists you with knowing the Fluorometholone API Price utilized in the formulation of products. Fluorometholone API Price is not always fixed or binding as the Fluorometholone Price is obtained through a variety of data sources. The Fluorometholone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A FML Liquifilm manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of FML Liquifilm, including repackagers and relabelers. The FDA regulates FML Liquifilm manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. FML Liquifilm API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of FML Liquifilm manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A FML Liquifilm supplier is an individual or a company that provides FML Liquifilm active pharmaceutical ingredient (API) or FML Liquifilm finished formulations upon request. The FML Liquifilm suppliers may include FML Liquifilm API manufacturers, exporters, distributors and traders.
click here to find a list of FML Liquifilm suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A FML Liquifilm DMF (Drug Master File) is a document detailing the whole manufacturing process of FML Liquifilm active pharmaceutical ingredient (API) in detail. Different forms of FML Liquifilm DMFs exist exist since differing nations have different regulations, such as FML Liquifilm USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A FML Liquifilm DMF submitted to regulatory agencies in the US is known as a USDMF. FML Liquifilm USDMF includes data on FML Liquifilm's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The FML Liquifilm USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of FML Liquifilm suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The FML Liquifilm Drug Master File in Japan (FML Liquifilm JDMF) empowers FML Liquifilm API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the FML Liquifilm JDMF during the approval evaluation for pharmaceutical products. At the time of FML Liquifilm JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of FML Liquifilm suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a FML Liquifilm Drug Master File in Korea (FML Liquifilm KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of FML Liquifilm. The MFDS reviews the FML Liquifilm KDMF as part of the drug registration process and uses the information provided in the FML Liquifilm KDMF to evaluate the safety and efficacy of the drug.
After submitting a FML Liquifilm KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their FML Liquifilm API can apply through the Korea Drug Master File (KDMF).
click here to find a list of FML Liquifilm suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing FML Liquifilm as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for FML Liquifilm API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture FML Liquifilm as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain FML Liquifilm and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a FML Liquifilm NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of FML Liquifilm suppliers with NDC on PharmaCompass.
FML Liquifilm Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of FML Liquifilm GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right FML Liquifilm GMP manufacturer or FML Liquifilm GMP API supplier for your needs.
A FML Liquifilm CoA (Certificate of Analysis) is a formal document that attests to FML Liquifilm's compliance with FML Liquifilm specifications and serves as a tool for batch-level quality control.
FML Liquifilm CoA mostly includes findings from lab analyses of a specific batch. For each FML Liquifilm CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
FML Liquifilm may be tested according to a variety of international standards, such as European Pharmacopoeia (FML Liquifilm EP), FML Liquifilm JP (Japanese Pharmacopeia) and the US Pharmacopoeia (FML Liquifilm USP).